Routine use of low-dose glucarpidase following high-dose methotrexate in adult patients with CNS lymphoma: an open-label, multi-center phase I study
2022 · BMC Cancer · 22 citations
https://doi.org/10.1186/s12885-021-09164-x
M
Mina Lobbous
Cleveland Clinic(US)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
101
Papers
321
Citations
8
h-index
7
i10-index
Mina Lobbous is an academic researcher from Cleveland Clinic. The author has contributed to research in topics: Glioma Diagnosis and Treatment & Brain Metastases and Treatment & CNS Lymphoma Diagnosis and Treatment. The author has an h-index of 8, co-authored 86 publications.
ORCID: 0000-0002-7034-2079Papers by this author
worksRacial and socioeconomic disparities in glioblastoma outcomes: A single‐center, retrospective cohort study
2023 · Cancer · 21 citations
https://doi.org/10.1002/cncr.34881
Tumor-related epilepsy in high-grade glioma: a large series survival analysis
2024 · Journal of Neuro-Oncology · 15 citations
https://doi.org/10.1007/s11060-024-04787-z
An evaluation of selumetinib for the treatment of neurofibromatosis type 1-associated symptomatic, inoperable plexiform neurofibromas
2021 · Expert Review of Precision Medicine and Drug Development · 3 citations
https://doi.org/10.1080/23808993.2021.1917989
Postoperative Seizure in Patients with Malignant Glioma Undergoing Tumor Resection with Intraoperative Mapping: Risk Factors, Management Strategies, and the Utility of Bayesian Analysis in a Case-Control Cohort
2026 · Research Square · 0 citations
https://doi.org/10.21203/rs.3.rs-8705953/v1
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat